Bone Biologics Co. (NASDAQ:BBLG – Get Free Report) was the recipient of a large increase in short interest during the month of September. As of September 15th, there was short interest totalling 28,700 shares, an increase of 129.6% from the August 31st total of 12,500 shares. Approximately 5.5% of the company’s shares are short sold. Based on an average daily trading volume, of 4,820,000 shares, the short-interest ratio is currently 0.0 days.
Bone Biologics Stock Performance
Bone Biologics stock opened at $2.35 on Friday. Bone Biologics has a 1 year low of $0.80 and a 1 year high of $10.56. The firm has a 50 day moving average price of $1.66 and a 200 day moving average price of $1.67.
Bone Biologics (NASDAQ:BBLG – Get Free Report) last issued its earnings results on Friday, August 9th. The company reported ($0.67) earnings per share for the quarter, topping the consensus estimate of ($1.39) by $0.72. Equities research analysts expect that Bone Biologics will post -3.17 earnings per share for the current fiscal year.
About Bone Biologics
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1.
Read More
- Five stocks we like better than Bone Biologics
- What Are Some of the Best Large-Cap Stocks to Buy?
- CarMax’s Impressive Rally: What Investors Should Watch Next
- What is Forex and How Does it Work?
- MarketBeat Week in Review – 9/23 – 9/27
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Wake Up to This Biotech Stock That Still Has Big Potential Upside
Receive News & Ratings for Bone Biologics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bone Biologics and related companies with MarketBeat.com's FREE daily email newsletter.